Retraction
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial
Paper Information
Record ID:
52779
Author(s):
Journal:
Publication Date:
November 07, 2022
Retraction Date:
March 11, 2024
(1.7 year years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt
- Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Shebeen El-Kom, Egypt
- Department of Neuropsychiatry, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt
- Zoology Department, Faculty of Science, Damanhour University, Damanhour, Egypt
- Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina, Saudi Arabia
- Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt
Countries:
Article Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations2
Post-Retraction(50.0%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
296
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
IUPHAR review: Drug Repurposing in Schizophrenia – An Updated Review of Clinical Trials
Jihan K. Zaki, Jakub Tomasik, Sabine Bahn
Pharmacological Research
Open Access
Published: Jan 2025
1 citation
1 citation
296 days after retraction
Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: A randomized, double-blind, placebo-controlled trial
Ahmad Shamabadi, Elham-Sadat Rafiei-Tabatabaei, Kimia Kazemzadeh et al. (7 authors)
The International Journal of Neuropsychopharmacology
Open Access
Published: Nov 2024
2 citations
2 citations
235 days after retraction
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial
Mahmoud S. Abdallah, Esraa M. Mosalam, Ahmed Hassan et al. (8 authors)
CNS Neuroscience & Therapeutics
Open Access
Published: Nov 2022
3 citations
3 citations
490 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025